昨年、Retractable Technologies Incは最も業績の良かった部門であるSyringesで24.91M USDの売上を計上しました。地域別ではUnited Statesが最も大きく貢献し、昨年の売上高は32.24M USDに達しました。直近の四半期において、Retractable Technologies Incは2026-06-30に終了した期間の売上高として6.25M USDを報告しました。これは最も好調な部門であるSyringesによるものです。地域別ではUnited Statesが最も高く、5.87M USDを貢献しました。

事業別

収益

比率

年間

年間

四半期

Syringes

EasyPoint Needles

Blood Cllection Products

Other Products

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

Syringes

24.91M(65.10%)

22.63M(68.47%)

34.16M(78.34%)

86.74M(91.48%)

176.33M(93.60%)

68.73M(83.96%)

35.64M(85.27%)

28.27M(84.95%)

EasyPoint Needles

11.94M(31.21%)

8.95M(27.08%)

7.25M(16.63%)

4.67M(4.93%)

9.64M(5.12%)

9.63M(11.76%)

2.98M(7.13%)

3.41M(10.26%)

Blood Cllection Products

1.37M(3.58%)

1.43M(4.31%)

1.93M(4.42%)

2.95M(3.12%)

2.25M(1.19%)

2.36M(2.89%)

2.72M(6.50%)

1.42M(4.28%)

Other Products

43.63K(0.11%)

45.85K(0.14%)

266.27K(0.61%)

451.95K(0.48%)

167.56K(0.09%)

1.14M(1.39%)

464.05K(1.11%)

172.41K(0.52%)

地域別

収益

比率

年間

年間

四半期

United States

North and South America(excluding U.S)

Other International

Sales to U.S. government

HHS Order sales to U.S. Government

North and South America sales

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

FY2012

FY2011

United States

32.24M(84.24%)

29.37M(88.88%)

34.60M(79.36%)

36.49M(38.49%)

53.89M(28.61%)

42.17M(51.51%)

31.90M(76.32%)

28.65M(86.09%)

27.02M(78.32%)

26.31M(88.20%)

23.03M(77.93%)

27.65M(80.10%)

24.84M(80.70%)

25.36M(75.39%)

26.66M(83.03%)

North and South America(excluding U.S)

5.06M(13.22%)

1.96M(5.93%)

6.09M(13.96%)

29.13M(30.72%)

14.56M(7.73%)

6.89M(8.42%)

8.25M(19.74%)

3.60M(10.81%)

--(--)

Other International

968.61K(2.53%)

1.71M(5.19%)

2.91M(6.68%)

13.47M(14.20%)

6.27M(3.33%)

1.17M(1.42%)

1.65M(3.95%)

1.03M(3.10%)

1.10M(3.18%)

776.87K(2.60%)

853.44K(2.89%)

1.22M(3.53%)

1.49M(4.84%)

3.61M(10.74%)

710.16K(2.21%)

Sales to U.S. government

--(--)

15.73M(16.59%)

113.66M(60.34%)

--(--)

HHS Order sales to U.S. Government

--(--)

31.63M(38.64%)

--(--)

North and South America sales

--(--)

6.38M(18.50%)

2.74M(9.19%)

5.67M(19.18%)

5.65M(16.37%)

4.45M(14.47%)

4.67M(13.88%)

4.74M(14.75%)